New research from 23and ME sheds a light on why GLP-1 weight-loss drugs work differently across patients, with two studies suggesting that genetic variation and cardiovascular mechanisms independent of weight loss may both play significant roles in determining individual outcomes
MEDVi may require initial lab work before starting treatment to ensure GLP-1s are safe and appropriate for you
Gastroparesis can interfere with normal digestion and cause nausea, vomiting (including vomiting of undigested food), abdominal pain, abdominal bloating, severe dehydration, a feeling of fullness after eating just a few bites, undigested food hardening and remaining in the stomach, acid reflux, changes in blood sugar levels, lack of appetite, weight loss, malnutrition, and a decreased quality of life, the lawsuit states
Timing matters because both supplements rely on absorption, metabolism, and how your body prioritises repair during the day
Peer review Peer review information Nature thanks Dipender Gill, Ruth Loos and the other, anonymous, reviewer(s) for their contribution to the peer review of this work